Competitor Analysis: CD19-Targeted Therapeutics
Reportstack, provider of premium market research reports announces the addition of Competitor Analysis: CD19-Targeted Therapeutics market report to its offering
The human CD19 antigen is a 95 kd transmembrane glycoprotein. It is specifically expressed in normal and neoplastic B cells, as well as follicular dendritic cells. CD19 serves as a diagnostic marker for B-cell malignancies. Virtually all cases of acute lymphoblastic leukemia (ALL) are CD19 positive. Years ago, naked antibodies have been generated against CD19, but clinical results were not...
View full press release